Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 9/20 | 0.44 |
| ▸ | CNR1 | P21554 | 6/20 | 0.44 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.39 |
| ▸ | PFKFB2 | O60825 | 1/20 | 0.34 |
| ▸ | PFKFB1 | P16118 | 1/20 | 0.34 |
| ▸ | PFKFB3 | Q16875 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 6/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | RET | P07949 | 1/20 | 0.31 |
| ▸ | IGF1R | P08069 | 1/20 | 0.31 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.31 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.31 |
| ▸ | FLT1 | P17948 | 1/20 | 0.31 |
| ▸ | LTK | P29376 | 1/20 | 0.31 |
| ▸ | AXL | P30530 | 1/20 | 0.31 |
| ▸ | KDR | P35968 | 1/20 | 0.31 |
| ▸ | FLT3 | P36888 | 1/20 | 0.31 |
| ▸ | MST1R | Q04912 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23722038 | 0.95 | SOS1 (0.41) | CNR2CNR1SOS1KDM1A | |
| SCHEMBL23745833 | 0.92 | CNR2 (0.44) | CNR2CNR1PFKFB2PFKFB1PFKFB3 | |
| Hydrochloric Acid SCHEMBL23721937 | 0.91 | CNR2 (0.43) | CNR2CNR1PFKFB2PFKFB1PFKFB3 | |
| SCHEMBL23745604 | 0.89 | CNR2 (0.42) | CNR2CNR1SOS1 | |
| SCHEMBL23745598 | 0.89 | SOS1 (0.44) | CNR2CNR1SOS1 | |
| Hydrochloric Acid SCHEMBL23722144 | 0.89 | CNR2 (0.41) | CNR2CNR1SOS1 | |
| Hydrochloric Acid SCHEMBL23722114 | 0.88 | SOS1 (0.44) | CNR2CNR1SOS1 | |
| SCHEMBL23745522 | 0.85 | CNR2 (0.44) | CNR2CNR1PFKFB2PFKFB1PFKFB3 | |
| Hydrochloric Acid SCHEMBL23722112 | 0.84 | CNR2 (0.44) | CNR2CNR1PFKFB2PFKFB1PFKFB3 | |
| SCHEMBL23745514 | 0.83 | SOS1 (0.48) | CNR1SOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210246115-A1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | BIOIMICS AB (SE) | 2021-08-12 | — | — | US | disclosed |
| US-20210246115-A1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | BIOIMICS AB (SE) | 2021-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210246115-A1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | FDPS, FPR1, F12 | CNR2 2528/4885CNR1 1651/4885SOS1 2902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.